CTKB vs DAL · rev $200.5M vs P/E 12, rev $61.64B
Cytek Biosciences Inc (CTKB) versus Delta Air Lines Inc (DAL) — a side-by-side from cached financials, not a winner call.
Cytek Biosciences Inc (CTKB) is a medical devices company listed on US.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Latest reported CTKB revenue for 2024-12-31 was $200.5M. Net income was -$6.0M. Revenue was up 3.9% from 2023-12-31 to 2024-12-31. CTKB currently screens at market cap $421.8M.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
CTKB currently screens at market cap $421.8M. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Not investment advice. Open the CTKB and DAL stock pages for the full models.
Not investment advice.